Page last updated: 2024-08-24

25-hydroxycholesterol and Pneumonia, Viral

25-hydroxycholesterol has been researched along with Pneumonia, Viral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Q; Cheng, G; Deng, YQ; Gold, S; He, J; Li, J; Li, L; Li, X; Li, XF; Qin, CF; Yang, H; Zhang, C; Zhao, H; Zhou, C; Zu, S	1

Other Studies

1 other study(ies) available for 25-hydroxycholesterol and Pneumonia, Viral

Article	Year
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell research, 2020, Volume: 30, Issue:11 Topics: Aged; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Disease Models, Animal; Fatal Outcome; Female; Humans; Hydroxycholesterols; Mice; Mice, Inbred BALB C; Mice, Transgenic; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Virus Replication	2020

Article

Year

25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor.

Cell research, 2020, Volume: 30, Issue:11

Topics: Aged; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Disease Models, Animal; Fatal Outcome; Female; Humans; Hydroxycholesterols; Mice; Mice, Inbred BALB C; Mice, Transgenic; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Virus Replication

2020